Clinical evaluation of anisotropine methyl bromide (Valpin®), an anticholinergic drug

@article{Bachrach2005ClinicalEO,
  title={Clinical evaluation of anisotropine methyl bromide (Valpin{\textregistered}), an anticholinergic drug},
  author={William H. Bachrach},
  journal={The American Journal of Digestive Diseases},
  year={2005},
  volume={17},
  pages={505-512}
}
  • W. Bachrach
  • Published 1 June 1972
  • Medicine, Psychology
  • The American Journal of Digestive Diseases
The administration of anisotropine methyl bromide to patients with a variety of gastrointestinal disorders, most of which were functional gastroenteropathies, brought symptomatic relief only to a minority. These disappointing results were reflected further in the outcome of a double-blind study in 100 patients in whom, when the randomized drug numbers were decoded, therapeutic responses and side effects were not significantly different from those of patients receiving a placebo. 

References

SHOWING 1-2 OF 2 REFERENCES

Anticholinergic drugs

  • W. Bachrach
  • Medicine, Biology
    The American Journal of Digestive Diseases
  • 2005
None of the anticholinergics has been proved to manifest unique specificity for any particular gastrointestinal organ, function, or segment of the gastrointestinal tract, and there is no single anticholine of choice for any gastrointestinal ailment, unless it be atropine or belladonna because of their greatly lower cost.

The pharmacology of placebos.

  • S. Wolf
  • Medicine
    Pharmacological reviews
  • 1959